Author

Tiantong Liu

Magee-Womens Research InstituteORCID 0000-0002-3780-9431Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Adrian V. LeeiD· 3 shared Jennifer M. AtkinsoniD· 3 shared Steffi OesterreichiD· 3 shared Ahmed BasudaniD· 2 shared Jagmohan HoodaiD· 2 shared Nilgun TasdemiriD· 2 shared Osama Shiraz ShahiD· 2 shared Peter C. LucasiD· 2 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Adrian V. LeeORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 31, 2026

Breast cancer ovarian metastases show increased activity of GPCR pathways

Laura Savariau, Ye Qin, Osama Shiraz Shah…·Steffi Oesterreich

The paper identifies increased GPCR pathway activity in breast cancer ovarian metastases and links it to migration and F-actin reorganization through CaSR.

DOI 10.64898/2026.07.30.741805

humanwhole-exome sequencing

𝕏 PostBluesky

Cancer BiologyEndocrinologyPeer-reviewedAug 27, 2024

ESR1 fusion proteins invoke breast cancer subtype-dependent enrichment of ligand independent pro-oncogenic signatures and phenotypes

Megan E. Yates, Hunter Waltermire, Kanako Mori…·Steffi Oesterreich

This study shows ER fusion proteins in breast cancer cell lines drive ligand-independent pro-oncogenic pathways, with subtype- and fusion-specific effects.

11 citations

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintSep 15, 2023

WCRC-25: A novel luminal Invasive Lobular Carcinoma cell line model

Ashuvinee Elangovan, Emily A. Bossart, Ahmed Basudan…·Steffi Oesterreich

The paper introduces a new invasive lobular carcinoma cell line, WCRC-25, and demonstrates its molecular features and therapeutic response to PI3K/AKT inhibition.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky